Antipsychotic drugs, menstrual regularity and osteoporosis risk.
- Published in:
- Archives of Women's Mental Health, 2002, v. 5, n. 3, p. 93, doi. 10.1007/s00737-002-0002-4
- By:
- Publication type:
- Article
Works matching IS 14341816 AND DT 2002 AND VI 5 AND IP 3
Results: 8
1
2
A clinical trial of adjunctive oestrogen treatment in women with schizophrenia.
- Published in:
- Archives of Women's Mental Health, 2002, v. 5, n. 3, p. 99, doi. 10.1007/s00737-002-0001-5
- By:
- Publication type:
- Article
3
Neuroprotective effects of estradiol-17β: implications for psychiatric disorders.
- Published in:
- Archives of Women's Mental Health, 2002, v. 5, n. 3, p. 105
- By:
- Publication type:
- Article
4
Oestrogen effects in schizophrenia and their potential therapeutic implications – Review.
- Published in:
- Archives of Women's Mental Health, 2002, v. 5, n. 3, p. 111, doi. 10.1007/s00737-002-0003-3
- By:
- Publication type:
- Article
5
Acute psychiatric admission and menstrual cycle phase in women with schizophrenia.
- Published in:
- Archives of Women's Mental Health, 2002, v. 5, n. 3, p. 119, doi. 10.1007/s00737-002-0004-2
- By:
- Publication type:
- Article
6
Contents Journal of Psychosomatic Obstetrics and Gynecology Volume 23, Issue 3, September 2002.
- Published in:
- Archives of Women's Mental Health, 2002, v. 5, n. 3, p. 127, doi. 10.1007/s007370200027
- Publication type:
- Article
7
Calendar.
- Published in:
- Archives of Women's Mental Health, 2002, v. 5, n. 3, p. 128, doi. 10.1007/s007370200028
- Publication type:
- Article
8
Oestrogens and schizophrenia – Introduction.
- Published in:
- Archives of Women's Mental Health, 2002, v. 5, n. 3, p. 91, doi. 10.1007/s007370200026
- By:
- Publication type:
- Article